title: Metabolomics reveals that tumor xenografts induce liver dysfunction.
abstract: Metabolomics, based on ultraperformance liquid chromatography coupled with electrospray ionization quadrupole mass spectrometry, was used to explore metabolic signatures of tumor growth in mice. Urine samples were collected from control mice and mice injected with squamous cell carcinoma (SCCVII) tumor cells. When tumors reached ∼2 cm, all mice were killed and blood and liver samples collected. The urine metabolites hexanoylglycine, nicotinamide 1-oxide, and 11β,20α-dihydroxy-3-oxopregn-4-en-21-oic acid were elevated in tumor-bearing mice, as was asymmetric dimethylarginine, a biomarker for oxidative stress. Interestingly, SCCVII tumor growth resulted in hepatomegaly, reduced albumin/globulin ratios, and elevated serum triglycerides, suggesting liver dysfunction. Alterations in liver metabolites between SCCVII-tumor-bearing and control mice confirmed the presence of liver injury. Hepatic mRNA analysis indicated that inflammatory cytokines, tumor necrosis factor α, and transforming growth factor β were enhanced in SCCVII-tumor-bearing mice, and the expression of cytochromes P450 was decreased in tumor-bearing mice. Further, genes involved in fatty acid oxidation were decreased, suggesting impaired fatty acid oxidation in SCCVII-tumor-bearing mice. Additionally, activated phospholipid metabolism and a disrupted tricarboxylic acid cycle were observed in SCCVII-tumor-bearing mice. These data suggest that tumor growth imposes a global inflammatory response that results in liver dysfunction and underscore the use of metabolomics to temporally examine these changes and potentially use metabolite changes to monitor tumor treatment response.
authors: Laboratory of Metabolism, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors: Fei
authors: F
authors: Li
authors: Andrew D
authors: AD
authors: Patterson
authors: Kristopher W
authors: KW
authors: Krausz
authors: Changtao
authors: C
authors: Jiang
authors: Huichang
authors: H
authors: Bi
authors: Anastasia L
authors: AL
authors: Sowers
authors: John A
authors: JA
authors: Cook
authors: James B
authors: JB
authors: Mitchell
authors: Frank J
authors: FJ
authors: Gonzalez
mesh_terms: D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D008107:Liver Diseases / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D055432:Metabolomics; D051379:Mice; D008809:Mice, Inbred C3H; D014183:Transplantation, Heterologous / Q000009:adverse effects*; D047368:Tumor Burden
references: Atherosclerosis. 2011 Feb;214(2):310-5
references: 21146169
references: Mol Endocrinol. 2007 Sep;21(9):2136-51
references: 17550978
references: Nature. 2009 Feb 12;457(7231):910-4
references: 19212411
references: Phys Med Biol. 2011 Feb 7;56(3):535-56
references: 21212470
references: Am J Physiol Regul Integr Comp Physiol. 2009 Feb;296(2):R195-200
references: 18685064
references: J Proteome Res. 2011 Nov 4;10(11):5232-41
references: 21961579
references: Anal Bioanal Chem. 2011 Oct;401(6):1899-904
references: 21833635
references: Hepatology. 2011 Apr;53(4):1282-93
references: 21480330
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 15;879(24):2369-75
references: 21763219
references: Biochem Pharmacol. 2012 May 15;83(10):1435-44
references: 22387617
references: Nat Med. 2011 Mar;17(3):291-3
references: 21383741
references: J Proteome Res. 2012 Feb 3;11(2):1354-63
references: 22148915
references: Cell Cycle. 2010 Sep 1;9(17):3485-505
references: 20861672
references: J Biol Chem. 2012 Jul 13;287(29):24784-94
references: 22619174
references: J Toxicol Environ Health A. 2010;73(21-22):1420-30
references: 20954069
references: Curr Med Chem. 2013;20(2):257-71
references: 23210853
references: Chem Res Toxicol. 2009 Apr;22(4):699-707
references: 19256530
references: Vasc Med. 2005 Jul;10 Suppl 1:S19-25
references: 16444865
references: Bioinformatics. 2009 Dec 1;25(23):3151-7
references: 19783829
references: Magn Reson Med. 2013 May;69(5):1443-50
references: 22692861
references: Nat Genet. 2008 Oct;40(10):1230-4
references: 18806796
references: Clin Cancer Res. 2007 Aug 15;13(16):4928-33
references: 17699873
references: Anal Chem. 2008 Feb 1;80(3):665-74
references: 18173289
references: Radiat Med. 1997 May-Jun;15(3):149-53
references: 9278371
references: J Lipid Res. 2012 Aug;53(8):1625-35
references: 22665165
references: Oncogene. 2001 Oct 25;20(48):7085-95
references: 11704832
references: Drug Metab Rev. 1997 Nov;29(4):1129-88
references: 9421688
references: Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17992-7
references: 20855610
references: J Biol Chem. 2011 Jun 3;286(22):19511-22
references: 21487016
references: Int J Cancer. 2010 Dec 15;127(12):2841-50
references: 21351263
references: Mol Cell Proteomics. 2011 Jul;10(7):M110.004945
references: 21518826
references: J Inherit Metab Dis. 2008 Aug;31(4):550
references: 18649007
references: Exp Cell Res. 1999 Nov 25;253(1):230-8
references: 10579925
references: Br J Cancer. 2008 Jan 15;98(1):91-7
references: 18059400
references: Cancer Res. 2012 Jul 15;72(14):3471-9
references: 22628425
references: Clin Pharmacol Ther. 2008 Jun;83(6):894-7
references: 18388870